{"filings":[{"id":99845,"accession_number":"0000927066-26-000060","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DaVita Q1 2026 adj EPS $2.87 vs $2.00 YoY; revenue $3.416B, repurchased 3M shares","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP and adjusted diluted EPS $2.87, up 44% YoY from $2.00; down sequentially from $3.40 in Q4 2025.","Consolidated revenue $3.416B; operating income $482M; operating cash flow $321M; free cash flow $140M.","Repurchased 3.0M shares at avg price $133.70 per share during Q1 2026.","CEO Javier Rodriguez highlighted clinical excellence and durable results; net income from continuing ops $198M."],"consensus_eps_estimate":null,"consensus_eps_actual":2.87,"consensus_revenue_estimate":null,"consensus_revenue_actual":3415548000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116096,"accession_number":"0000927066-26-000004","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DaVita Q4 adj. EPS $3.40 vs $2.51 Q3; full-year net income down YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $3.620B, operating income $561M, adj. operating income $586M.","Q4 adj. diluted EPS $3.40; full-year 2025 adj. diluted EPS $10.78 (2024: $9.68).","Full-year 2025 net income from continuing ops $722M ($9.51 diluted EPS) vs 2024 $936M ($10.73).","Repurchased 2.7M shares in Q4 at avg $122.78; 12.7M shares in 2025 at avg $140.09.","Refinanced Term Loan A-1 and revolver; earlier in 2025 issued $6.75% senior notes due 2033."],"consensus_eps_estimate":null,"consensus_eps_actual":9.84,"consensus_revenue_estimate":null,"consensus_revenue_actual":13643069000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132540,"accession_number":"0001206774-25-000750","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2025-11-25T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"DaVita refinances $3.5B in credit facilities; JPMorgan replaces Wells Fargo as agent","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Entered $2.0B secured term loan A facility (New A-2 Term Facility) and $1.5B secured revolving credit facility (New Revolving Facility).","New facilities refinance existing ~$1.95B term loan and $1.5B revolver both maturing April 2028.","Proceeds used to repay prior facilities, pay fees, and for working capital and general corporate purposes including stock repurchases and acquisitions.","JPMorgan Chase Bank appointed as administrative agent, collateral agent, and swingline lender, replacing Wells Fargo.","New A-2 Term Facility amortizes quarterly beginning March 2026 at 2.5% p.a. first two years then 5.0% p.a. thereafter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132539,"accession_number":"0000927066-25-000163","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2025-10-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DaVita Q3 2025 EPS $2.04, revenue $3.42B, in line with guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Diluted EPS of $2.04; adjusted diluted EPS of $2.51.","Consolidated revenue of $3.420 billion.","Operating income of $506M; adjusted operating income of $517M.","Operating cash flow $842M; free cash flow $604M.","Repurchased 3.3 million shares at average $140.67 per share."],"consensus_eps_estimate":null,"consensus_eps_actual":6.62,"consensus_revenue_estimate":null,"consensus_revenue_actual":10023282000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149073,"accession_number":"0000927066-25-000154","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2025-08-20T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"DaVita board authorizes additional $2 billion share repurchase program","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized $2,000,000,000 in additional repurchasing authority under existing share repurchase program.","New Authorization does not replace the $1.0B September 2024 authorization; both remain active with no expiration.","Repurchases may be executed via open market, accelerated share repurchases, tender offers, or Rule 10b5-1 plans.","Company retains right to suspend or discontinue either authorization at any time, subject to credit facility limits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149072,"accession_number":"0000927066-25-000122","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DaVita Q2 2025: EPS $2.58 ($2.95 adj.); revenue $3.38B; $1B notes issued","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Diluted EPS $2.58 ($2.95 adjusted); net income $199M vs Q1 $163M.","Revenue $3.38B; operating income $538M; adjusted operating income $551M.","Issued $1.0B of 6.75% senior notes to repay revolving credit line.","Repurchased 3.1M shares at average price $144.00 per share.","Operating cash flow $324M; free cash flow $157M."],"consensus_eps_estimate":null,"consensus_eps_actual":4.57,"consensus_revenue_estimate":null,"consensus_revenue_actual":6603055000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149071,"accession_number":"0001193125-25-160501","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2025-07-17T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"DaVita reprices $1.88B term loan B, cuts margin 25 bps, adds $250M incremental debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Seventh Amendment to Credit Agreement reprices $1.628B Extended Tranche B-1 Term Loans into Tranche B-2 at 175 bps (Term SOFR) and 75 bps (Base Rate), down from 200/100 bps.","Incurs $250M Incremental Tranche B-2 Term Loans; proceeds used to repay $250M of senior secured term A loans maturing April 2028.","Total Tranche B-2 Term Loans outstanding ~$1.88B; new loans mature May 2031, matching original maturity.","Repricing and incremental borrowing effective July 17, 2025; conditions include customary representations and no default."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168050,"accession_number":"0000927066-25-000107","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2025-06-09T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"DaVita stockholders elect all nine directors, ratify KPMG, approve say-on-pay at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All nine director nominees elected with >97% votes cast in favor; broker non-votes ~6.4M shares.","Ratification of KPMG as independent auditor passed with 66,500,682 votes for (95.6% of votes cast).","Advisory approval of executive compensation passed with 59,322,425 votes for (93.9% of votes cast).","69,548,287 shares represented (~90% of outstanding) at the virtual meeting held June 5, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168049,"accession_number":"0001206774-25-000378","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"DaVita closes $1.0B offering of 6.750% Senior Notes due 2033","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1.0B aggregate principal of 6.750% senior notes maturing July 15, 2033.","Net proceeds of ~$986M after discount and fees; will repay $830M of revolver borrowings.","Interest payable semiannually on Jan 15 and Jul 15, starting Jan 15, 2026.","Notes are unsecured, rank equally with existing senior debt; guaranteed by certain domestic subsidiaries.","Redeemable at make-whole premium before Jul 15, 2028; thereafter at specified prices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168048,"accession_number":"0001206774-25-000369","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2025-05-20T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"DaVita upsizes and prices $1B of 6.750% Senior Notes due 2033","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Offering increased from $750M to $1B aggregate principal; notes priced at 100.000% with 6.750% coupon.","Closing expected May 23, 2025 subject to customary conditions.","Proceeds to repay outstanding revolver borrowings, fees, and general corporate purposes including stock repurchases.","Notes offered under Rule 144A/Reg S; not registered under Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168047,"accession_number":"0001206774-25-000368","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2025-05-20T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"DaVita announces private offering of $750M Senior Notes due 2033","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$750M aggregate principal amount of 2033 Senior Notes offered in private placement.","Net proceeds to repay revolving credit facility borrowings and related fees and expenses.","Remaining proceeds for general corporate purposes including stock repurchases, working capital, and capex.","Offering limited to qualified institutional buyers under Rule 144A and non-U.S. persons under Reg S."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168046,"accession_number":"0000927066-25-000085","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DaVita Q1 2025: revenue $3.22B, EPS $2.00, net income $163M down 32% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Consolidated revenues $3.224B; operating income $439M.","Net income $163M, diluted EPS $2.00, down from $240M and $2.65 in Q1 2024.","Operating cash flow $180M; free cash flow negative $45M.","Repurchased 3.7M shares at average price $148.94 per share."],"consensus_eps_estimate":null,"consensus_eps_actual":2.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":3223529000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168045,"accession_number":"0001193125-25-079593","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2025-04-14T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"DaVita reports ransomware incident on April 12; operations impacted, patient care continues","summary_kind":"llm","event_type":"cyber","confidence":"high","bullets":["Ransomware encrypted certain network elements; DaVita isolated impacted systems and activated response protocols.","Company working with third-party cybersecurity professionals and notified law enforcement.","Patient care continues but some operations disrupted; interim measures implemented for restoration.","Full scope, nature, and ultimate impact not yet known; duration of disruption uncertain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185274,"accession_number":"0000927066-25-000009","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2025-02-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DaVita Q4 adjusted EPS $2.24, revenue $3.295B; full year EPS $10.73","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2024 revenue $3.295B; operating income $565M; diluted EPS $3.09 (adjusted $2.24).","FY 2024 revenue $12.816B; net income $936M; diluted EPS $10.73 (adjusted $9.68).","FY 2024 net income up 35% YoY ($936M vs $692M); diluted EPS up from $7.42.","Repurchased 2.3M shares in Q4 at avg $156.46; total 9.8M shares in FY 2024.","CEO: full year adjusted results in top half of guidance range; 2025 outlook positive."],"consensus_eps_estimate":null,"consensus_eps_actual":10.73,"consensus_revenue_estimate":null,"consensus_revenue_actual":12815550000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201861,"accession_number":"0000927066-24-000177","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2024-10-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DaVita Q3 2024: revenue $3.264B, op income $535M, EPS $2.50, adj EPS $2.59","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Consolidated revenue $3.264B; operating income $535M; net income $215M ($2.50 diluted EPS).","Adjusted diluted EPS $2.59; nine-month net income $677M vs $541M YoY.","Incurred $1.1B Term Loan A-1 and issued $1.0B 6.875% senior notes; repaid ~$950M Term Loan B-1 and revolver.","Repurchased 2.7M shares at avg $147.20 per share during Q3.","Operating cash flow $810M; free cash flow $555M."],"consensus_eps_estimate":null,"consensus_eps_actual":7.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":9520867000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217897,"accession_number":"0001206774-24-000897","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2024-09-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"DaVita appoints David P. Maughan as COO, Kidney Care; Staffieri becomes COO Emeritus","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["David P. Maughan appointed COO, DaVita Kidney Care, effective September 15, 2024, succeeding Michael D. Staffieri.","Maughan previously SVP overseeing home and hospital services, HR, IT, marketing, and state government affairs.","Employment agreement provides $725,000 base salary and 2024 target bonus of 100% of base salary earned.","Severance includes benefits under DaVita Severance Plan; enhanced to 2-year base salary if Good Cause resignation within 2 years post-change-of-control."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217896,"accession_number":"0000927066-24-000162","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2024-09-05T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"DaVita board approves $2B increase to share repurchase program","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board added $2B in repurchase authority; no expiration date, no obligation to repurchase.","Repurchases may occur via open market, private deals, or existing agreement with Berkshire Hathaway.","Bylaws amended to revise stockholder nomination and meeting procedures; effective immediately."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217895,"accession_number":"0001206774-24-000784","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2024-08-14T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"DaVita issues $1.0B of 6.875% senior notes due 2032 and obtains $1.1B term loan facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1.0B aggregate principal of 6.875% Senior Notes due September 1, 2032.","Entered $1.1B Incremental Term Loan A-1 Facility maturing April 28, 2028.","Net proceeds of ~$2.08B used to repay $950M Tranche B-1 Term Loans and $60M revolving loans.","Additional $350M revolving loans to be repaid; remainder for general corporate purposes.","Sixth Amendment removed cap on incremental term loan borrowings under credit agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217894,"accession_number":"0001206774-24-000776","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2024-08-09T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"DaVita prices $1.0B of 6.875% Senior Notes due 2032; proceeds for debt repayment","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$1.0B aggregate principal, 6.875% coupon, priced at par, due 2032; closing August 13, 2024.","Proceeds to repay Term Loan B-1 (2026) and revolver borrowings; includes accrued interest and fees.","Any remaining proceeds for general corporate purposes, including share repurchases and capex.","Offering is a private placement under Rule 144A/Reg S; not registered under Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217893,"accession_number":"0001206774-24-000769","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"DaVita launches $1.0B senior notes due 2032; proceeds to repay Term Loan B-1 and revolver","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$1.0B aggregate principal of Senior Notes due 2032 in a private offering under Rule 144A/Reg S.","Proceeds to repay outstanding Term Loan B-1 (maturing 2026) and revolving credit facility borrowings.","Also expects incremental $1.0B Term Loan A Facility substantially concurrently with closing.","Remaining proceeds may fund stock repurchases, working capital, and capital expenditures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217892,"accession_number":"0000927066-24-000126","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DaVita Q2 2024 EPS $2.50, revenue $3.187B; raises adjusted EPS to $2.59","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $223M, diluted EPS $2.50; adjusted EPS $2.59 on revenue of $3.187B.","Operating income $506M; operating cash flow $799M, free cash flow $654M.","Extended maturity on $1.64B Term Loan B-1; repurchased 2.7M shares at $140.14 avg.","Six-month net income $462M vs $294M YoY; diluted EPS $5.15 vs $3.17."],"consensus_eps_estimate":null,"consensus_eps_actual":5.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":6257277000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":237813,"accession_number":"0000927066-24-000115","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2024-06-10T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"DaVita holds 2024 annual meeting; all director nominees elected, KPMG ratified, say-on-pay approved","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Ten director nominees elected with majority support; broker non-votes of ~6.96M.","Ratification of KPMG as independent auditor for FY2024 passed: 75.7M for, 3.0M against.","Advisory vote on named executive officer compensation approved: 68.0M for, 3.7M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":237812,"accession_number":"0000927066-24-000093","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"DaVita extends $1.64B term loan maturity to 2031, adds $658M incremental term loans","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Extended $1,640,250,847 of existing secured term loans from August 2026 to May 2031.","Added $657,884,309 in incremental term loans; proceeds used to repay non-extended portion.","Interest rate: Term SOFR + 200 bps or Base Rate + 100 bps.","Quarterly amortization at 1% per annum beginning December 31, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":237811,"accession_number":"0000927066-24-000089","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DaVita Q1 2024 net income $240M, EPS $2.65; revenue $3.07B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $3.071B; operating income $484M; adjusted operating income $463M.","Diluted EPS $2.65 (up from $1.25 in Q1 2023); adjusted diluted EPS $2.38 (vs $1.58).","Operating cash flow $(135)M; free cash flow $(327)M due to working capital timing.","Repurchased 2.1M shares at average price $112.76 per share.","CEO cites continued operational discipline and investment in clinical excellence."],"consensus_eps_estimate":null,"consensus_eps_actual":2.65,"consensus_revenue_estimate":null,"consensus_revenue_actual":3070555000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":237810,"accession_number":"0000927066-24-000083","cik":927066,"company_name":"DAVITA INC.","ticker":"DVA","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"DaVita enters share repurchase agreement with Berkshire Hathaway to cap ownership at 45%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Agreement requires DaVita to repurchase shares from Berkshire quarterly if ownership exceeds 45% of outstanding.","Immediate repurchase triggered if Berkshire ownership exceeds 49.5%.","Berkshire agrees to vote any shares beneficially owned above 40% as per board recommendation.","Existing standstill agreement from February 2022 remains in effect.","Repurchase price is volume-weighted average price paid by DaVita for open-market repurchases in the period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":12513863873.422098,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}